Key facts
- Proprio’s last known valuation is $145.0M.
- It has raised $81.8M across 2 recorded rounds; the latest was Early Stage VC ($23.0M) in Mar 2020.
- Notable investors include Nvidia, DCVC, Intel Capital, Acequia Capital, Trousdale Ventures — 24 tracked in total.
- Proprio has filed 3 Form Ds with the SEC since 2020, most recently Jul 2021 ($5.0M sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Proprio
Funding rounds
2 roundsAbout Proprio
Developer of a surgical technology company designed to improve surgical accuracy, simplify surgical workflows, and enhance patient outcomes. The company uses advancements in light field computer vision and artificial intelligence (AI) and synthesizes data from multiple inputs for navigating anatomy and surgical environments in a three-dimensional (3D) environment, helping medical professionals to improve clinical and economic outcomes by leveraging advanced artificial intelligence (AI) and data collection capabilities with the potential to provide predictive intelligence in surgery.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2016
- Employees
- 40
- Website
- propriovision.com/
- Ownership
- Privately Held (backing)
Proprio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Proprio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Proprio in its N-PORT filings yet. We sweep new filings monthly.